| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |